Sphingolipids
Products Related to Sphingolipids(340)
- GC11079C6 Ceramide (d18:1/6:0)CAS: 124753-97-5Purity: >98.00%
C6 Ceramide (d18:1/6:0) est un analogue de la céramide courte - chaîne, cellule - perméable qui a été utilisé pour rechercher la préclinique pour imiter les effets de la céramide endogène.
- GC12604Fumonisin B1CAS: 116355-83-0Purity: >98.00%
La fumonisine B1 est une mycotoxine produite par F. moniliforme, un champignon prévalent dans le maïs et d'autres céréales.
- GC18328SphingomyelinsCAS: 383907-87-7Purity: >98%
Sphingomyelins sont les sphingolipides majoritaires des membranes des cellules mammaliennes, et cette classe de lipides est particulièrement enrichie dans le membrane plasmique.
- GC18387GlucocerebrosidesCAS: 497155-61-0Purity: >98.00%
Glucocerebrosides are formed by the tethering of glucose to a ceramide by glucosylceramide synthase.
- GC18469Galactosylcerebrosides (bovine)CAS: 85305-88-0Purity: >98.00%
Galactosylcerebrosides are glycosphingolipids that contain a galactose attached to a ceramide acylated with hydroxy and non-hydroxy fatty acids.
- GC186091-Deoxysphinganine (m18:0)CAS: 196497-48-0Purity: >95.00%
La 1-désoxysphinganine (m18:0) (ES-285) est un composé antiprolifératif (antitumoral) d'origine marine. La 1-désoxysphinganine (m18:0) inhibe la croissance des cellules prostatiques PC-3 et LNCaP par accumulation intracellulaire de céramide et PKC&zeta ; Activation.
- GC40016Ganglioside GM2 Mixture (sodium salt)CAS: 19600-01-2Purity: >98.00%
Ganglioside GM2 is a glycosphingolipid component of cellular membranes, primarily the plasma membrane.
- GC40104Sphingosine-d7 (d18:1)CAS: 1246304-34-6Purity: >99.00%
La sphingosine-d7 (d18:1) (érythrosphingosine-d7) est la D-érythro-sphingosine marquée au deutérium. La D-érythro-sphingosine (érythrosphingosine) est un activateur très puissant de la p32-kinase avec une EC50 de 8 μ ; M, et inhibe la protéine kinase C (PKC). La D-érythro-Sphingosine (Erythrosphingosine) est également un activateur de la PP2A.
- GC40140C18 3'-sulfo Lactosylceramide (d18:1/18:0)CAS: 1292769-63-1Purity: >98.00%
C18 3'-sulfo Lactosylceramide (d18:1/18:0) is a sulfated glycosphingolipid.
- GC40141C18 Phytoceramide-d3 (t18:0/18:0-d3)CAS: 1354806-91-9Purity: >99.00%
C18 Phytoceramide-d3 (t18:0/18:0-d3) is intended for use as an internal standard for the quantification of C18 phytoceramide (t18:0/18:0) by GC- or LC-MS.
- GC40142Lactosylceramides (bovine buttermilk)CAS: 4682-48-8Purity: >98.00%
Lactosylceramide (LacCer) is an endogenous bioactive sphingolipid.
- GC40209C6 dihydro 1-Deoxyceramide (m18:0/6:0)Purity: >98.00%
C6 dihydro 1-Deoxyceramide (m18:0/6:0) is a short-chain atypical ceramide containing a 1-deoxysphinganine (m18:0) backbone.
- GC40210C6 1-Deoxyceramide (m18:1(14Z)/6:0)Purity: >95.00%
C6 1-Deoxyceramide (m18:1(14Z)/6:0) is a short-chain atypical ceramide containing a 1-deoxysphingosine (m18:1(14Z)) backbone with a cis double bond at the 14-15 position rather than a trans double bond at the 4-5 position.
- GC40296D-erythro-MAPPCAS: 143492-38-0Purity: >98.00%
Le D-érythro-MAPP (D-e-MAPP) est un inhibiteur de la céramidase, avec une IC50 de 1-5 μM in vitro.
- GC40688C6 D-threo Ceramide (d18:1/6:0)CAS: 189894-79-9Purity: >98.00%
C6 D-threo Ceramide is a bioactive sphingolipid and cell-permeable analog of naturally occurring ceramides., C6 D-threo Ceramide is cytotoxic to U937 cells in vitro (IC50 = 18 μM).
- GC40689C6 L-erythro Ceramide (d18:1/6:0)CAS: 189894-78-8Purity: >98.00%
C6 L-erythro Ceramide is a bioactive sphingolipid and cell-permeable analog of naturally occurring ceramides.
- GC40690C6 L-threo Ceramide (d18:1/6:0)CAS: 189894-80-2Purity: >98.00%
C6 L-threo Ceramide (d18:1/6:0) est un sphingolipide bioactif et un analogue perméable aux cellules des céramides naturels.
- GC40708C2 L-erythro Ceramide (d18:1/2:0)CAS: 150338-90-2Purity: >98.00%
C2 L-erythro Ceramide is a bioactive sphingolipid and a cell-permeable analog of naturally occurring ceramides.
- GC40709C2 L-threo Ceramide (d18:1/2:0)CAS: 143615-69-4Purity: >98.00%
C2 L-threo Ceramide is a bioactive sphingolipid and cell-permeable analog of naturally occurring ceramides.
- GC40770L-erythro Sphingosine (d18:1)CAS: 6036-75-5Purity: >98.00%
L-erythro Sphingosine is a synthetic stereoisomer of sphingosine (d18:1).
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC11079 | C6 Ceramide (d18:1/6:0) | 124753-97-5 | >98.00% | |
C6 Ceramide (d18:1/6:0) est un analogue de la céramide courte - chaîne, cellule - perméable qui a été utilisé pour rechercher la préclinique pour imiter les effets de la céramide endogène. | ||||
| GC12604 | Fumonisin B1 | 116355-83-0 | >98.00% | |
La fumonisine B1 est une mycotoxine produite par F. moniliforme, un champignon prévalent dans le maïs et d'autres céréales. | ||||
| GC18328 | Sphingomyelins | 383907-87-7 | >98% | |
Sphingomyelins sont les sphingolipides majoritaires des membranes des cellules mammaliennes, et cette classe de lipides est particulièrement enrichie dans le membrane plasmique. | ||||
| GC18387 | Glucocerebrosides | 497155-61-0 | >98.00% | |
Glucocerebrosides are formed by the tethering of glucose to a ceramide by glucosylceramide synthase. | ||||
| GC18469 | Galactosylcerebrosides (bovine) | 85305-88-0 | >98.00% | |
Galactosylcerebrosides are glycosphingolipids that contain a galactose attached to a ceramide acylated with hydroxy and non-hydroxy fatty acids. | ||||
| GC18609 | 1-Deoxysphinganine (m18:0) | 196497-48-0 | >95.00% | |
La 1-désoxysphinganine (m18:0) (ES-285) est un composé antiprolifératif (antitumoral) d'origine marine. La 1-désoxysphinganine (m18:0) inhibe la croissance des cellules prostatiques PC-3 et LNCaP par accumulation intracellulaire de céramide et PKC&zeta ; Activation. | ||||
| GC18757 | CAY10444 | 298186-80-8 | >98.00% | |
CAY10444 est un antagoniste du récepteur 3 de la sphingosine-1-phosphate (S1P3). CAY10444 peut inhiber la libération d'ions calcium provoquée par S1P dans les cellules CHO exprimant S1P3 humain (valeur d'IC50 de 11,6μM). | ||||
| GC19852 | 4-Methylumbelliferyl-α-D-glucopyranoside | 17833-43-1 | >99.00% | |
| GC26281 | C24 Ceramide (d18:1/24:0) | 102917-80-6 | >99.00% | |
| GC40016 | Ganglioside GM2 Mixture (sodium salt) | 19600-01-2 | >98.00% | |
Ganglioside GM2 is a glycosphingolipid component of cellular membranes, primarily the plasma membrane. | ||||
| GC40104 | Sphingosine-d7 (d18:1) | 1246304-34-6 | >99.00% | |
La sphingosine-d7 (d18:1) (érythrosphingosine-d7) est la D-érythro-sphingosine marquée au deutérium. La D-érythro-sphingosine (érythrosphingosine) est un activateur très puissant de la p32-kinase avec une EC50 de 8 μ ; M, et inhibe la protéine kinase C (PKC). La D-érythro-Sphingosine (Erythrosphingosine) est également un activateur de la PP2A. | ||||
| GC40140 | C18 3'-sulfo Lactosylceramide (d18:1/18:0) | 1292769-63-1 | >98.00% | |
C18 3'-sulfo Lactosylceramide (d18:1/18:0) is a sulfated glycosphingolipid. | ||||
| GC40141 | C18 Phytoceramide-d3 (t18:0/18:0-d3) | 1354806-91-9 | >99.00% | |
C18 Phytoceramide-d3 (t18:0/18:0-d3) is intended for use as an internal standard for the quantification of C18 phytoceramide (t18:0/18:0) by GC- or LC-MS. | ||||
| GC40142 | Lactosylceramides (bovine buttermilk) | 4682-48-8 | >98.00% | |
Lactosylceramide (LacCer) is an endogenous bioactive sphingolipid. | ||||
| GC40209 | C6 dihydro 1-Deoxyceramide (m18:0/6:0) | - | >98.00% | |
C6 dihydro 1-Deoxyceramide (m18:0/6:0) is a short-chain atypical ceramide containing a 1-deoxysphinganine (m18:0) backbone. | ||||
| GC40210 | C6 1-Deoxyceramide (m18:1(14Z)/6:0) | - | >95.00% | |
C6 1-Deoxyceramide (m18:1(14Z)/6:0) is a short-chain atypical ceramide containing a 1-deoxysphingosine (m18:1(14Z)) backbone with a cis double bond at the 14-15 position rather than a trans double bond at the 4-5 position. | ||||
| GC40296 | D-erythro-MAPP | 143492-38-0 | >98.00% | |
Le D-érythro-MAPP (D-e-MAPP) est un inhibiteur de la céramidase, avec une IC50 de 1-5 μM in vitro. | ||||
| GC40688 | C6 D-threo Ceramide (d18:1/6:0) | 189894-79-9 | >98.00% | |
C6 D-threo Ceramide is a bioactive sphingolipid and cell-permeable analog of naturally occurring ceramides., C6 D-threo Ceramide is cytotoxic to U937 cells in vitro (IC50 = 18 μM). | ||||
| GC40689 | C6 L-erythro Ceramide (d18:1/6:0) | 189894-78-8 | >98.00% | |
C6 L-erythro Ceramide is a bioactive sphingolipid and cell-permeable analog of naturally occurring ceramides. | ||||
| GC40690 | C6 L-threo Ceramide (d18:1/6:0) | 189894-80-2 | >98.00% | |
C6 L-threo Ceramide (d18:1/6:0) est un sphingolipide bioactif et un analogue perméable aux cellules des céramides naturels. | ||||
| GC40708 | C2 L-erythro Ceramide (d18:1/2:0) | 150338-90-2 | >98.00% | |
C2 L-erythro Ceramide is a bioactive sphingolipid and a cell-permeable analog of naturally occurring ceramides. | ||||
| GC40709 | C2 L-threo Ceramide (d18:1/2:0) | 143615-69-4 | >98.00% | |
C2 L-threo Ceramide is a bioactive sphingolipid and cell-permeable analog of naturally occurring ceramides. | ||||
| GC40757 | CAY10734 | 635701-59-6 | >98.00% | |
An S1P 1 receptor agonist | ||||
| GC40770 | L-erythro Sphingosine (d18:1) | 6036-75-5 | >98.00% | |
L-erythro Sphingosine is a synthetic stereoisomer of sphingosine (d18:1). | ||||